Check out deals on ebay.
SAN DIEGO (AP) — Arena Pharmaceuticals Inc. said Monday that European Union regulators have accepted its marketing application for lorcaserin, its experimental weight loss drug.
Arena did not say when it expects the European Medicines Agency to render a decision. The company said a panel of Food and Drug Administration advisers will review the drug on May 10. Shares of Arena Pharmaceuticals rose 41 cents, or 17 percent, to $2.82 in morning trading. Earlier shares set a 52-week high of $2.88.
Arena is seeking approval to market lorcaserin for patients who are overweight or obese and have at least one health problem related to their weight. Its main ingredient is intended to stimulate serotonin receptors in the brain, making patients feel satisfied with what they have eaten. The FDA refused to approve lorcaserin in October 2010 because the agency was not convinced it was effective, and was concerned about links to tumors when the drug was studied on rats.
Arena and its partner, Japanese drugmaker Eisai, have since sent more information about the drug to regulators. The FDA is scheduled to make a new ruling on the drug by June 27.
Why not check out our Phen375 review?